inositol has been researched along with c-peptide in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, T; Murase, T; Nakanishi, K; Oki, Y; Okubo, M; Tanaka, S | 1 |
| Campbell, WW; Evans, WJ; Farrell, PA; Joseph, LJ; Ostlund, RE | 1 |
| Birge, ZK; Campbell, WW; Fluckey, JD; Haub, MD; Hulver, MW; Morse-Carrithers, H; Ostlund, RE; Thyfault, JP | 1 |
| Han, KA; Kim, HJ; Kim, YK; Ku, BJ; Lee, SK; Min, KW; Park, KS | 1 |
| Fujii, M; Ichikawa, M; Imagawa, M; Inaba, S; Kimura, T; Konoshita, T; Miyamori, I; Sato, S; Suzuki, J; Takahashi, S; Zenimaru, Y | 1 |
| Artini, PG; Cela, V; Di Berardino, OM; Genazzani, AD; Papini, F; Ruggiero, M; Simi, G | 1 |
4 trial(s) available for inositol and c-peptide
| Article | Year |
|---|---|
Pinitol supplementation does not affect insulin-mediated glucose metabolism and muscle insulin receptor content and phosphorylation in older humans.
Topics: Aged; Blood Glucose; C-Peptide; Dietary Supplements; Fasting; Female; Glucose Tolerance Test; Humans; Inositol; Insulin; Male; Middle Aged; Muscle, Skeletal; Phosphorylation; Phosphotyrosine; Placebos; Receptor, Insulin | 2004 |
Effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus.
Topics: Adipokines; Adiponectin; Adult; Aged; Blood Glucose; C-Peptide; C-Reactive Protein; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Inositol; Insulin Resistance; Male; Middle Aged; Milk Proteins; Treatment Outcome; Whey Proteins | 2012 |
Differential effects of α-glucosidase inhibitors on postprandial plasma glucose and lipid profile in patients with type 2 diabetes under control with insulin lispro mix 50/50.
Topics: 1-Deoxynojirimycin; Apolipoprotein A-I; Blood Glucose; C-Peptide; Cross-Over Studies; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin Lispro; Lipids; Lipoproteins, HDL; Male; Middle Aged; Postprandial Period; Treatment Outcome; Triglycerides | 2012 |
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study.
Topics: Blood Glucose; Body Mass Index; C-Peptide; Drug Therapy, Combination; Estradiol; Female; Folic Acid; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Inositol; Insulin; Insulin Resistance; Luteinizing Hormone; Polycystic Ovary Syndrome; Prolactin; Testosterone; Treatment Outcome | 2013 |
2 other study(ies) available for inositol and c-peptide
| Article | Year |
|---|---|
Diabetes mellitus secondary to glycogen storage disease type III.
Topics: Age of Onset; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Disease Progression; Enzyme Inhibitors; Glycogen Storage Disease Type III; Glycoside Hydrolase Inhibitors; Humans; Inositol; Insulin; Male; Middle Aged | 2000 |
Relationships of plasma C-peptide and gender to the urinary excretion of inositols in older people.
Topics: Aged; Area Under Curve; Blood Glucose; Body Composition; C-Peptide; Diet; Female; Glucose Tolerance Test; Humans; Inositol; Insulin; Male; Middle Aged; Sex Characteristics | 2001 |